Liver test comparison for fatty liver disease
Part of Digestive system, Hormones & metabolism clinical trials.
This study checks if a simple blood test (LIVERFASt) can accurately measure liver fat and scarring compared to MRI. It may help patients avoid more invasive tests in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a type of fatty liver disease called MASLD or MetALD.
- You have had an MRI elastography (MRE) test that measures liver stiffness or scarring in the past.
- You have had a LIVERFASt blood test in the past.
- Your LIVERFASt test result includes at least a fibrosis (scarring) score.
- You do not have severe hemolysis (breaking down of red blood cells), acute hepatitis, or very high liver enzymes (ALT ≥ 600).
- You do not have other medical conditions that could interfere with the diagnosis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new blood test to help diagnose fatty liver disease and liver fibrosis. It aims to see how well the test works compared with a liver biopsy. Your participation could help improve diagnosis for others.
This study aims to find a simple way to detect liver fibrosis, a condition where the liver becomes scarred, in people who have risk factors like being overweight, having type 2 diabetes, or drinking alcohol heavily. By identifying fibrosis early, it may help prevent more serious liver problems.
This study is testing whether advanced imaging and other non-invasive methods can properly identify people with significant liver scarring due to metabolic liver disease or alcohol-related liver disease. It may help find better ways to track liver health without repeated needle biopsies.
This study looks at a new non-invasive screening method to predict metabolic dysfunction–associated steatotic liver disease (MASLD), a condition where fat builds up in the liver. The goal is to help identify people who may be at risk without needing invasive tests.
This study looks at blood test results in people with fatty liver disease to find common blood abnormalities. It may help doctors better understand and manage the condition.
This study tests a new device called LiverScope® that scans your liver to detect fatty liver disease (MASLD). The scan uses special imaging technology and may help doctors diagnose liver disease more quickly and accurately.
Hear when a new Liver Fibrosis Due to NASH trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.